Article Details

Monoclonal Antibody Highly Effective in Phase III Psoriasis Trial

Retrieved on: 2021-02-05 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

Monoclonal Antibody Highly Effective in Phase III Psoriasis Trial. View article details on hiswai:

Excerpt

The monoclonal antibody bimekizumab was more effective than ustekinumab (Stelara) or placebo for moderate-to-severe plaque psoriasis in a phase ...

Article found on: www.medpagetoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up